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Abstract
Segmental colitis associated with diverticulosis is a pathology of recent knowl-
edge, whose pathogenesis is still poorly defined. Diagnosis is mainly based on 
colonoscopy and histopathological study. Clinical features are chronic diarrhea, 
abdominal cramps in the lower right quadrant, and intermittent hematochezia. 
The diagnosis is evidenced by colonoscopy showing inflammation in the colic 
mucosa between the diverticula, sparing the diverticular orifice associated with an 
anatomopathological condition showing chronic inflammation. The involvement 
is preferably sigmoid and may involve a descending colon, sparing the rectum. 
The treatment is similar to that of inflammatory bowel diseases in mild forms, but 
recent studies have presented new alternatives with good results. The treatment 
is not yet well defined, and antibiotics, mesalamine, and corticoid therapy can be 
used, and surgery can even be performed for refractory cases.
Keywords: segmental colitis associated with diverticulosis, diverticular disease, 
inflammatory bowel diseases
1. Introduction
Colonic diverticular disease occurs in over 60% of people over 60 in the West. 
It can present various forms of manifestation, from asymptomatic conditions 
detected in endoscopic or imaging exams, to cases of acute diverticulitis, with a 
pericolic inflammatory process originating in a diverticulum and spreading to 
adjacent tissues due to micro-perforations [1, 2].
Segmental colitis associated with diverticulosis (SCAD) is a chronic inflamma-
tory change that occurs in colonic mucosal segments between colonic diverticula, 
limited to the sigmoid and left colon, generally not affecting the diverticular ostium 
[2–6]. Rectum and right colon are spared from any endoscopic and histological 
inflammation [5, 6]. It is a recently recognized pathology within the spectrum of 
manifestations of colonic diverticular disease [7].
The inflammation of the colonic mucosa may resemble other inflamma-
tory bowel diseases (IBD) [Crohn’s disease (CD) and ulcerative colitis (UC)] 
in both clinical and endoscopic aspects [3, 7, 8]. Inflammation is non-specific, 
non-granulomatous, and localized. It appears to be a self-limited inflammatory 
process [3, 9].
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2. Terminology
Several terms have been used to refer to this pathology, including crescentic fold 
disease, colitis associated with diverticular disease, diverticular colitis, diverticular-
associated colitis (DAC), or segmental colitis associated with diverticulosis 
(SCAD), this being the most currently accepted [3, 9].
3. Pathogenesis
The exact pathogenic mechanism is not known, but it appears to be multifacto-
rial pathogenesis [10]. Several hypotheses have been raised, including mucosal pro-
lapse leading to mucosal ischemia, fecal stasis within diverticula, and consequent 
dysbiosis that can trigger an immune response, and high exposure to intraluminal 
antigens and toxins [3–5, 11].
4. Epidemiology
It is a rare pathology, with a prevalence ranging from 0.3 to 1.3% of patients 
undergoing colonoscopy [7] and 1.15 to 11.4% of patients with colonic diverticula.
The mean age at diagnosis is 61.7 to 66.5 years, similar to the mean age of onset 
of diverticular disease of the colon [3, 4]. There is also a predominance of males 
(58.7%) [4, 9].
5. Associated factors
SCAD is believed to be associated with several factors, including changes in intesti-
nal motility, bacterial stasis in the colon, bacterial overgrowth, and inflammation [3].
6. Clinical condition
Although SCAD is still considered a pathology among the spectrum of diverticu-
lar diseases, it differs from diverticulitis (which is the inflammation of a diverticu-
lum). As consequence, also the clinical picture is different.
The clinical picture associated with SCAD is variable, with studies citing 
complaints of diarrhea, rectal bleeding (live or with other changes), abdominal 
pain, and tenesmus [3, 4, 10]. Fever and weight loss are rare [4]. More than a third 
of patients have at least two associated symptoms at diagnosis [12].
The clinical picture can be very similar to that of mild inflammatory bowel 
disease. Occasionally, the patient may be asymptomatic, and the diagnosis is made 
only at random during colonoscopy for another reason.
Symptoms may vary according to the subtype of SCAD presented, with diarrhea 
being more common in type A and rectal bleeding in types C and D [12]. Type B 
presents with more than one symptom 39% of the time, with diarrhea and rectal 
bleeding being the main ones. Abdominal pain is more frequent in types C and D [2].
7. Laboratory and radiological exams
Laboratory tests (blood count, white blood count, erythrocyte sedimentation rate, 
C-reactive protein, fecal inflammatory markers, fecal calprotectin) and radiological 
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tests do not show specific results, but help to exclude differential diagnoses [4, 13]. 
Computed tomography may show thickening of the colonic wall in a colon segment 
with pre-existing diverticulosis. Fat blurring can be seen occasionally [14].
8. Diagnosis
The diagnosis of SCAD must initially be performed excluding other pathologies 
that cause intestinal inflammation, among these differential diagnoses: ischemic coli-
tis, colitis induced by anti-inflammatory drugs, infectious colitis (mainly cytomegalo-
virus and Clostridium difficile), and IBD [3]. SCAD can mimic clinical and endoscopic 
presentations of IBD [10], and some pictures are indistinguishable from IBD [7].
Colonoscopy is the mainstay for the diagnosis of SCAD [15]. By its use, inflam-
mation restricted to the mucosa between the diverticula is detected, sparing the 
diverticular orifice [3, 4]. Inflammation basically affects the sigmoid colon and left 
colon with normal mucosa in the rest of the colon (Figure 1).
It is indicated to perform biopsies of affected areas and normal areas to accurately 
locate inflammatory changes [15]. It is also suggested to perform a rectal biopsy 
(whose result should be negative) to strengthen the diagnosis [3, 7]. The pathologist 
must be informed about the clinical suspicion for better elucidation of the case.
Histopathologically, SCAD presents an active inflammatory infiltrate, similar to 
ulcerative colitis, unlike colonic diverticular disease, which presents a nonspecific 
inflammatory infiltrate, sometimes active, but different from those of inflamma-
tory bowel diseases [5, 16, 17].
Therefore, it is concluded that the diagnosis must include colonoscopy and his-
topathological examination, confirming the inflammatory process in the affected 
area, and ruling out inflammation in other areas, in addition to laboratory and 
imaging tests excluding other pathologies.
9. Classification
SCAD can be classified endoscopically into four categories considering the 
absence of diverticulitis (Table 1) [3, 12, 14, 18, 19]:
The feature that unifies the four types of SCAD is the fact that it saves diverticu-
lar orifice. The main points used to classify SCAD in the different categories are how 
much it resembles or does not have mild-to-moderate UC, severe UC, or CD [12].
In the figures below, taken from Tursi, 2010, we observe endoscopic and histo-
pathological images of SCAD type A (Figure 2), SCAD type B (Figure 3), SCAD 
type C (Figure 4), and SCAD type D (Figure 5) [2].
Figure 1. 
Endoscopic appearance of a case of SCAD. A large, swollen, and red lesion on the top of the colonic fold can be 
seen: This lesion could be scored as type A SCAD.
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Figure 2. 
Segmental colitis associated with diverticulosis’ as “crescentic fold disease.” The endoscopic pattern shows a 
swollen red patch about 1 cm in diameter, without hemorrhage or ulceration, confined to the crescentic mucosal 
fold. The diverticular orifices are spared, as well as the vascular pattern of the colonic mucosa is spared (a). 
The histopathological pattern shows an acute-on-chronic inflammation. Two crypt abscesses are evident in the 
center of the field (Hematoxylin & Eosin, magnification x20) (b).
Type Pattern Endoscopic appearance Histological appearance
A Crescentic fold Swollen red patches as of 0.5 
to 1.5 cm in diameter.
Without architectural changes in the 
crypts.
Neutrophil and lymphocyte infiltrate are 
limited to crypt epithelium.
B Mild to 
moderate 
UC-like
Diffuse loss of vascular 
pattern, mucosal edema 
and hyperemia, and diffuse 
erosions.
Active inflammation with architectural 
changes in the crypt, crypt abscesses, and 
goblet cell depletion.
Chronic changes of the lamina propria.
C Crohn’s 
colitis-like
Isolated aphthous ulcers. Highest variability. Transmural 
inflammation with microfissures.
Lymphoid follicles and non-specific 
infiltrates.
D Severe UC-like As type B but more severe 
with diffuse ulceration 
and reduced caliber of the 
lumen.
Crypt architectural changes, diffuse 
cryptitis, crypt abscesses, and goblet cell 
depletion.
Chronic changes of the lamina propria.
Table 1. 
SCAD classification (endoscopic and histological appearance).
5
Segmental Colitis Associated with Diverticulosis
DOI: http://dx.doi.org/10.5772/intechopen.100580
Figure 3. 
Segmental colitis associated with diverticulosis as “Mild-to-moderate ulcerative colitis-like.” the endoscopic 
pattern shows patchy loss of vascular pattern, edema, and hyperemia of the mucosa, and diffuse erosions. All 
diverticular orifices are spared (a). The histopathological pattern shows an acute-on-chronic inflammation. 
Two crypt abscesses are evident in the center of the field. There is also slight disarray and an architectural 
distortion with crypts irregularly arranged and varying in size and shape, patchy lymphoplasmacytic 
inflammation with some eosinophils (Hematoxylin & Eosin, magnification x100) (b).
Figure 4. 
Segmental colitis associated with diverticulosis as “Crohn’s disease colitis-like.” The endoscopic pattern shows 
scattered aphthous ulcers, some of them on the crescentic mucosal fold, within a normal colonic mucosa, with 
the normal vascular pattern. The diverticular orifices are always spared (a). The histopathological pattern 
shows a patchy lymphoplasmacytic inflammation in the upper part of the field, without significant cryptic 
architectural changes, and with a lymphoid follicle (count lymphocyte assay, magnification x20) (b).
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10. Treatment
Since SCAD can resemble inflammatory diseases. It could be treated following 
the precepts of mild forms of IBD [3]. It is considered more benign than other IBD, 
with some patients evolving with full resolution of the condition without recur-
rences, even without any type of treatment being established [4, 10]. Types A and C 
SCAD seem to show a milder evolution, while types B and D have a high propensity 
to relapse, being highly indicated a more aggressive clinical and endoscopic follow-
up and treatment for these two types [12, 20].
The standard treatment for SCAD is still not well defined, and it is possible to 
use a high fiber diet, use antibiotics (e.g., ciprofloxacin 500 mg twice a day associ-
ated with metronidazole 500 mg three times a day for 7 days) and aminosalicylates 
(mesalamine 2.4 to 3.2 g per day) in cases of unsatisfactory response to antibiotics 
or recurrent symptoms, which can be continued for 7 to 10 days or have its dose 
increased in case of therapeutic failure [4, 10, 14]. Immunosuppressants and 
steroids are used in severe third-line cases [4, 10].
In case of recurrence after having responded to the use of antibiotic therapy, we 
suggest repeating the same regimen for a long time.
Recent studies have demonstrated the possibility of combining beclomethasone 
dipropionate (BDP) (for 4 weeks) and the probiotic VSL#3 (for 15 days in a row) 
for the treatment of mild-to-moderate acute conditions, with the vast majority of 
patients reaching remission in week 4 [4, 10].
Figure 5. 
Segmental colitis associated with diverticulosis as “Severe ulcerative colitis-like” SCAD pattern. The endoscopic 
pattern shows marked edema in the sigmoid mucosa with ulcerations, reduction of the lumen, diffuse loss of 
vascular pattern, diffuse hyperemia, and easy bleeding on contact with colonoscopy. The diverticular orifices 
are not easy to recognize, but they may be visible, spared by inflammation, at the maximal air inflation (a). 
Histology showed severe active ulcerative colitis (indistinguishable from classic inflammatory bowel disease), 
with severe diffuse inflammatory infiltrate, crypts irregularly arranged with architectural distortion, and 
cryptic abscesses (Hematoxylin & Eosin, magnification x40) (b).
7
Segmental Colitis Associated with Diverticulosis
DOI: http://dx.doi.org/10.5772/intechopen.100580
In patients’ refractory to conventional therapy for SCAD, infliximab and adalim-
umab could be good therapeutic options [5, 21–23].
Table 2 shows the medicament advice, posology, and suggested time of use.
Surgery reserved for cases refractory to clinical treatment or that become depen-
dent on corticosteroid therapy [4, 10].
It is always important to rethink whether the SCAD diagnosis is correct in 
case of failure of the instituted therapies, always bearing in mind the differential 
diagnoses, especially IBD [22].
The treatment algorithm for SCAD adapted from Kucej and Poggio 2018 is 
shown in Figure 6 and divides the therapeutic indications according to the SCAD 
classification [3].
Medicament Posology Usage time
Ciprofloxacin 500 mg twice a day 7–14 days
metronidazole 500 mg 3 times a day 7–14 days
Mesalamine 2.4 a 3.2 g per day Variable with the answer
Prednisone 40 mg + wean 7 days + weaning until week 6
Beclomethasone 
dipropionate
10 mg/day (1 month) + 5 mg/day  
(next month)
8 weeks
VSL#3 1 bag/day 15 days
Table 2. 
Medicament, posology, and usage time for SCAD.
Figure 6. 
Proposed algorithm for SCAD management (adapted by Tursi et al. [2]).
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